The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

CAMBRIDGE, Mass., November 12, 2024--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent ...

Truist raised the firm’s price target on Arcellx (ACLX) to $136 from $87 and keeps a Buy rating on the shares after its Q3 results. The ...

“We are delighted with the robust sales growth in the third quarter, during which we have continued to increase commercial capacity and deliver CARVYKTI to more multiple myeloma patients around the ...

2seventy Bio focuses on pioneering cell and gene therapies. Its lead product, Abecma, is a chimeric antigen receptor (CAR) ...

On the first day of the Chhath Mahaparv, Sharda Sinha, the voice synonymous with the four-day festivities in Bihar, Jharkhand ...

The global prevalence of blood cancers, including leukemia, lymphoma, and multiple myeloma, continues to rise. Blood malignancies are the fifth most common cancer globally, with over 300,000 people ...

Stand Up To Cancer ® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a combination of two types of targeted therapies, teclistamab and daratumumab , ...

Cellectar broadens global manufacturing network in preparation for potential commercialization of Iopofosine I 131 in 2025.

Canopy, the first Continuous Care Platform for oncology, today announced findings from two studies demonstrating the clinical impact of EHR-integrated Remote Therapeutic Monitoring for patients with ...

A heart-wrenching video of singer Sharda Sinha performing a Chhath Puja song from her hospital bed has gone viral on social ...